The importance of calcium-binding proteins in childhood diseases

Journal of Pediatrics

Volumn 147, Issue 6, 2005, Pages 731-738

  Heizmann, Claus W ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ADVANCED GLYCATION END PRODUCT; CALCITONIN; CALCIUM; CALCIUM BINDING PROTEIN; CALCIUM CHANNEL; CALCYCLIN; PARATHYROID HORMONE; PROTEIN S 100; PROTEIN S100B; VITAMIN D;

ALZHEIMER DISEASE; AMNESIA; AMYOTROPHIC LATERAL SCLEROSIS; AUTOIMMUNE DISEASE; BONE DEVELOPMENT; BONE METASTASIS; BRAIN DYSFUNCTION; CALCIFICATION; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CANCER; CARDIOMYOPATHY; CHILDHOOD DISEASE; CITRULLINEMIA; DISEASE ASSOCIATION; DOWN SYNDROME; HUMAN; HYPERPARATHYROIDISM; HYPOTHYROIDISM; JUVENILE RHEUMATOID ARTHRITIS; KIDNEY FAILURE; LEARNING DISORDER; MULTIPLE MYELOMA; OSTEOMALACIA; PANCREATITIS; PRIORITY JOURNAL; PSORIASIS; REVIEW; RHEUMATOID ARTHRITIS; RICKETS; SARCOIDOSIS; VITAMIN D DEFICIENCY;

EID: 28944437555     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2005.08.046     Document Type: Article

References (77)

1. R. Pochet R. Donato J. Haiech C.W. Heizmann V. Gerke Calcium: the molecular basis of calcium action in biology and medicine 2000 Kluwer Academic Publishers Boston
2. Molecular cell biology, Nature Reviews; 2003. Vol. 4.
3. J.N. Parker P.M. Parker Calcium a medical dictionary, and annotated research guide to internet references 2003 ICON Health Publications San Diego (CA)
4. C.M. Shanahan Mechanisms of vascular calcification in renal disease Clin Nephrol 63 2005 146 157
5. S.J. Soldin N. Rifai J.M.B. Hicks Biochemical Basis of Pediatric Disease 1992 AACC Press Washington (DC)
6. C.R. Scriver A.L. Beaudet W.S. Sly D. Valle 8th ed. The metabolic and molecular bases of inherited diseases Vol. 3 2001 McGraw-Hill New York 3827 3876
7. A.M. Hofer, and E.M. Brown Extracellular calcium sensing and signaling Nat Rev Mol Cell Biol 4 2003 530 538
8. S. Ringer A further contribution regarding the influence of different constituents of the blood on the contraction of the heart J Physiol 4 1883 29 43
9. M. Zaugg, and M.C. Schaub Cellular mechanisms in sympatho-modulation of the heart Br J Anaesth 93 2004 34 52
10. J. Prestle, F.R. Quinn, and G.L. Smith Ca(2+)-handling proteins and heart failure: novel molecular targets? Curr Med Chem 10 2003 967 981
11. M.J. Berridge, M.D. Bootman, and H.L. Roderick Calcium signaling: dynamics, homeostasis and remodeling Nat Rev Mol Cell Biol 4 2003 517 529
12. M. Scoote, and A.J. Williams Myocardial calcium signaling and arrhythmia pathogenesis Biochem Biophys Res Commun 322 2004 1286 1309
13. R. Surtees Inherited ion channel disorders Eur J Pediatr 159 2000 S199 S203
14. T.J. Jentsch, C.A. Hubner, and J.C. Fuhrmann Ion channels: function unraveled by dysfunction Nat Cell Biol 6 2004 1039 1047
15. E. Marban Cardiac channelopathies Nature 415 2002 213 218
16. C. Mullner, L.A. Broos, A.M. van den Maagdenberg, and J. Striessnig Familial hemiplegic migraine type 1 mutations K1336E, W1684R, and V1696I alter Cav2.1 Ca(2+) channel gating: evidence for beta-subunit isoform-specific effects J Biol Chem 279 2004 51844 51850
17. I. Splawski, K.W. Timothy, L.M. Sharpe, N. Decher, P. Kumar, and R. Bloise Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism Cell 119 2004 19 31
18. R. Ten Broeke, G. Folkerts, T. Leusink-Muis, H.J. Van der Linde, M. Villain, and M.K. Manion Calcium sensors as new therapeutic targets for airway hyperresponsiveness and asthma Faseb J 15 2001 1831 1833
19. K. Van Baelen, L. Dode, J. Vanoevelen, G. Callewaert, H. De Smedt, and L. Missiaen The Ca(2+)/Mn(2+) pumps in the Golgi apparatus Biochim Biophys Acta 1742 2004 103 112
20. V. Prasad, G.W. Okunade, M.L. Miller, and G.E. Shull Phenotypes of SERCA and PMCA knockout mice Biochem Biophys Res Commun 322 2004 1192 1203
21. H. Kawasaki, S. Nakayama, and R.H. Kretsinger Classification and evolution of EF-hand proteins Biometals 11 1998 277 295
22. C.W. Heizmann, G. Fritz, and B.W. Schafer S100 proteins: structure, functions and pathology Front Biosci 7 2002 d1356 d1368
23. R. Lang, A.V. Gomes, J. Zhao, P.R. Housmans, T. Miller, and J.D. Potter Functional analysis of a troponin I (R145G) mutation associated with familial hypertrophic cardiomyopathy J Biol Chem 277 2002 11670 11678
24. J.A. Rhyner, I. Durussel, J.A. Cox, E.C. Ilg, B.W. Schafer, and C.W. Heizmann Human recombinant alpha-parvalbumin and nine mutants with individually inactivated calcium- and magnesium-binding sites: biochemical and immunological properties Biochim Biophys Acta 1313 1996 179 186
25. I. Swoboda, A. Bugajska-Schretter, P. Verdino, W. Keller, W.R. Sperr, and P. Valent Recombinant carp parvalbumin, the major cross-reactive fish allergen: a tool for diagnosis and therapy of fish allergy J Immunol 168 2002 4576 4584
26. Y. Hamada, H. Tanaka, S. Ishizaki, M. Ishida, Y. Nagashima, and K. Shiomi Purification, reactivity with IgE and cDNA cloning of parvalbumin as the major allergen of mackerels Food Chem Toxicol 41 2003 1149 1156
27. J.C. Hirsch, A.R. Borton, F.P. Albayya, M.W. Russell, R.G. Ohye, and J.M. Metzger Comparative analysis of parvalbumin and SERCA2a cardiac myocyte gene transfer in a large animal model of diastolic dysfunction Am J Physiol Heart Circ Physiol 286 2004 H2314 H2321
28. F. Huq, D. Lebeche, V. Iyer, R. Liao, and R.J. Hajjar Gene transfer of parvalbumin improves diastolic dysfunction in senescent myocytes Circulation 109 2004 2780 2785
29. S. Diederichs, E. Bulk, B. Steffen, P. Ji, L. Tickenbrock, and K. Lang S100 family members and trypsinogens are predictors of distant metastasis and survival in early-stage non-small cell lung cancer Cancer Res 64 2004 5564 5569
30. I. Camby, N. Nagy, M.B. Lopes, B.W. Schafer, C.A. Maurage, and M.M. Ruchoux Supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas are characterized by a differential expression of S100 proteins Brain Pathol 9 1999 1 19
31. I. Camby, F. Lefranc, G. Titeca, S. Neuci, M. Fastrez, and L. Dedecken Differential expression of S100 calcium-binding proteins characterizes distinct clinical entities in both WHO grade II and III astrocytic tumours Neuropathol Appl Neurobiol 26 2000 76 90
32. K. Pelc, S. Vincent, M.M. Ruchoux, R. Kiss, R. Pochet, and E. Sariban Calbindin-d(28k): a marker of recurrence for medulloblastomas Cancer 95 2002 410 419
33. I. Marenholz, C.W. Heizmann, and G. Fritz S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature) Biochem Biophys Res Commun 322 2004 1111 1122
34. B.W. Moore A soluble protein characteristic of the nervous system Biochem Biophys Res Commun 19 1965 739 744
35. G. Fritz, and C.W. Heizmann 3D-structures of the Ca(2+)- and Zn(2+)-binding S100 proteins A. Messerschmidt W. Bode M. Cygler Handbook of metalloproteins Vol. 3 2004 John Wiley & Sons Chichester 529 540
36. C.W. Heizmann S100B protein in clinical diagnostics: assay specificity Clin Chem 50 2004 249 251
37. C.W. Heizmann Subtypes of S100 proteins must be identified BMJ 318 1999 538
38. R. Kiewitz, C. Acklin, B.W. Schafer, B. Maco, B. Uhrik, and F. Wuytack Ca2(+)-dependent interaction of S100A1 with the sarcoplasmic reticulum Ca(2+)-ATPase2a and phospholamban in the human heart Biochem Biophys Res Commun 306 2003 550 557
39. A. Remppis, T. Greten, B.W. Schafer, P. Hunziker, P. Erne, and H.A. Katus Altered expression of the Ca(2+)-binding protein S100A1 in human cardiomyopathy Biochim Biophys Acta 1313 1996 253 257
40. P. Most, A. Remppis, S.T. Pleger, E. Loffler, P. Ehlermann, and J. Bernotat Transgenic overexpression of the Ca(2+)-binding protein S100A1 in the heart leads to increased in vivo myocardial contractile performance J Biol Chem 278 2003 33809 33817
41. P. Most, S.T. Pleger, M. Volkers, B. Heidt, M. Boerries, and D. Weichenhan Cardiac adenoviral S100A1 gene delivery rescues failing myocardium J Clin Invest 114 2004 1550 1563
42. R. Kiewitz, C. Acklin, E. Minder, P.R. Huber, B.W. Schafer, and C.W. Heizmann S100A1, a new marker for acute myocardial ischemia Biochem Biophys Res Commun 274 2000 865 871
43. L. Mazzucchelli Protein S100A4: too long overlooked by pathologists? Am J Pathol 160 2002 7 13
44. S.R. Jenkinson, R. Barraclough, C.R. West, and P.S. Rudland S100A4 regulates cell motility and invasion in an in vitro model for breast cancer metastasis Br J Cancer 90 2004 253 262
45. M.V. Pedersen, L.B. Kohler, M. Grigorian, V. Novitskaya, E. Bock, and E. Lukanidin The Mts1/S100A4 protein is a neuroprotectant J Neurosci Res 77 2004 777 786
46. I. Ninomiya, T. Ohta, S. Fushida, Y. Endo, T. Hashimoto, and M. Yagi Increased expression of S100A4 and its prognostic significance in esophageal squamous cell carcinoma Int J Oncol 18 2001 715 720
47. N. Ambartsumian, J. Klingelhofer, M. Grigorian, C. Christensen, M. Kriajevska, and E. Tulchinsky The metastasis-associated Mts1(S100A4) protein could act as an angiogenic factor Oncogene 20 2001 4685 4695
48. L. Lauriola, F. Michetti, N. Maggiano, J. Galli, G. Cadoni, and B.W. Schafer Prognostic significance of the Ca(2+) binding protein S100A2 in laryngeal squamous-cell carcinoma Int J Cancer 89 2000 345 349
49. J. Markowitz, I. Chen, R. Gitti, D.M. Baldisseri, Y. Pan, and R. Udan Identification and characterization of small molecule inhibitors of the calcium-dependent S100B-p53 tumor suppressor interaction J Med Chem 47 2004 5085 5093
50. M.R. Fernandez-Fernandez, D.B. Veprintsev, and A.R. Fersht Proteins of the S100 family regulate the oligomerization of p53 tumor suppressor Proc Natl Acad Sci U S A 102 2005 4735 4740
51. A. Mueller, B.W. Schafer, S. Ferrari, M. Weibel, M. Makek, and M. Hochli The calcium binding protein S100A2 interacts with p53 and modulates its transcriptional activity J Biol Chem 291 2005 186 193
52. W. Nacken, J. Roth, C. Sorg, and C. Kerkhoff S100A9/S100A8: Myeloid representatives of the S100 protein family as prominent players in innate immunity Microsc Res Tech 60 2003 569 580
53. J. Roth, T. Vogl, C. Sorg, and C. Sunderkotter Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules Trends Immunol 24 2003 155 158
54. D. Foell, H. Wittkowski, I. Hammerschmidt, N. Wulffraat, H. Schmeling, and M. Frosch Monitoring neutrophil activation in juvenile rheumatoid arthritis by S100A12 serum concentrations Arthritis Rheum 50 2004 1286 1295
55. D. Foell, F. Ichida, T. Vogl, X. Yu, R. Chen, and T. Miyawaki S100A12 (EN-RAGE) in monitoring Kawasaki disease Lancet 361 2003 1270 1272
56. D. Kane, J. Roth, M. Frosch, T. Vogl, B. Bresnihan, and O. FitzGerald Increased perivascular synovial membrane expression of myeloid-related proteins in psoriatic arthritis Arthritis Rheum 48 2003 1676 1685
57. D. Hoyaux, A. Boom, L. Van den Bosch, N. Belot, J.J. Martin, and C.W. Heizmann S100A6 overexpression within astrocytes associated with impaired axons from both ALS mouse model and human patients J Neuropathol Exp Neurol 61 2002 736 744
58. Y.H. Chung, K.M. Joo, R.H. Nam, M.H. Cho, D.J. Kim, and W.B. Lee Decreased expression of calretinin in the cerebral cortex and hippocampus of SOD1G93A transgenic mice Brain Res 1035 2005 105 109
59. E.K. Akpek, S.H. Liu, R. Thompson, and J.D. Gottsch Identification of paramyosin as a binding protein for calgranulin C in experimental helminthic keratitis Invest Ophthalmol Vis Sci 43 2002 2677 2684
60. O.V. Moroz, G.G. Dodson, K.S. Wilson, E. Lukanidin, and I.B. Bronstein Multiple structural states of S100A12: a key to its functional diversity Microsc Res Tech 60 2003 581 592
61. L. Subramanian, and A.S. Polans Cancer-related diseases of the eye: the role of calcium and calcium-binding proteins Biochem Biophys Res Commun 322 2004 1153 1165
62. M. Rothermundt, M. Peters, J.H. Prehn, and V. Arolt S100B in brain damage and neurodegeneration Microsc Res Tech 60 2003 614 632
63. T. Mussack, J. Dvorak, T. Graf-Baumann, and M. Jochum Serum S-100B protein levels in young amateur soccer players after controlled heading and normal exercise Eur J Med Res 8 2003 457 464
64. F. Michetti, and D. Gazzolo S100B protein in biological fluids: a tool for perinatal medicine Clin Chem 48 2002 2097 2104
65. F. Michetti, and D. Gazzolo S100B testing in pregnancy Clin Chim Acta 335 2003 1 7
66. J. Undén, J. Bellner, M. Eneroth, C. Alling, T. Ingebrigtsen, and B. Romner Raised serum S100B levels after acute bone fractures without cerebral injury J Trauma 58 2005 59 61
67. M.A. Hofmann, S. Drury, C. Fu, W. Qu, A. Taguchi, and Y. Lu RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides Cell 97 1999 889 901
68. S.F. Yan, R. Ramasamy, Y. Naka, and A.M. Schmidt Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond Circ Res 93 2003 1159 1169
69. B. Liliensiek, M.A. Weigand, A. Bierhaus, W. Nicklas, M. Kasper, and S. Hofer Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response J Clin Invest 113 2004 1641 1650
70. J.L. Wautier, and A.M. Schmidt Protein glycation: a firm link to endothelial cell dysfunction Circ Res 95 2004 233 238
71. L. Feng, C. Matsumoto, A. Schwartz, A.M. Schmidt, D.M. Stern, and J. Pile-Spellman Chronic vascular inflammation in patients with type 2 diabetes: endothelial biopsy and RT-PCR analysis Diabetes Care 28 2005 379 384
72. M.E. Cooper Importance of advanced glycation end products in diabetes-associated cardiovascular and renal disease Am J Hypertens 17 2004 31S 38S
73. R. Petrova, Y. Yamamoto, K. Muraki, H. Yonekura, S. Sakurai, and T. Watanabe Advanced glycation endproduct-induced calcium handling impairment in mouse cardiac myocytes J Mol Cell Cardiol 34 2002 1425 1431
74. M. Brownlee, A. Cerami, and H. Vlassara Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications N Engl J Med 318 1988 1315 1321
75. M.M. Reddy, M.B. Reddy, and C.F. Reddy Scientific advances provide opportunities to improve pediatric environmental health J Pediatr 145 2004 153 156
76. M.F. McCarty The low-AGE content of low-fat vegan diets could benefit diabetics-though concurrent taurine supplementation may be needed to minimize endogenous AGE production Med Hypotheses 64 2005 394 398
77. H.J. Huttunen, and H. Rauvala Amphoterin as an extracellular regulator of cell motility: from discovery to disease J Intern Med 255 2004 351 366